Trial Profile
A Phase II Trial of Intravenous Cereport (RMP-7) and Carboplatin in Childhood Brain Tumours.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Labradimil (Primary) ; Carboplatin
- Indications Astrocytoma; Brain cancer; Ependymoma; Glioma; Medulloblastoma; Primitive neuroectodermal tumours
- Focus Therapeutic Use
- 19 Jan 2006 New trial record.